The Dow, Nasdaq and S&P 500 are now negative for the year after dropping about 5 percent in the past two sessions. Two veteran strategists tell CNBC's "Power Lunch" on Monday the market sell-off has created some opportunities for investors.
Kate Warne, investment strategist at Edward Jones, is adding stocks that are well-positioned and attractively valued, with the potential for rising dividends over time. One of her top picks is diversified pharmaceutical company Merck. "New immune-oncology drug Keytrude should help drive long-term growth as it receives approvals for additional cancers," Warne said.
Bill Stone, chief investment strategist at PNC Asset Management, believes now is not the time to sell stocks. "While the short-term behavior of stocks is unknowable and one should expect further volatility, a wholesale liquidation of stocks is unwarranted in our view," Stone said.
He is overweight consumer names like PepsiCo.
Merck and Pepsico are lower during trading.